Cardiovascular

Clinical impact of an EHR-integrated hyperkalemia management system: a real-world study of 10,934 episodes.

TL;DR

Implementation of the 'Serum Potassium Management Center System' was associated with improved quality of hyperkalemia care, as reflected by more favorable process indicators and disease burden-related outcomes.

Key Findings

The hyperkalemia standardized group had a significantly higher rate of hyperkalemia diagnosis compared to the routine care group.

  • Diagnosis rate was 19.00% in the standardized group versus 15.43% in the routine group.
  • Difference was statistically significant (p < 0.05).
  • The study analyzed 10,934 hyperkalemia episodes in total.
  • This was a retrospective real-world implementation study.

The hyperkalemia standardized group had a significantly higher rate of hyperkalemia treatment compared to the routine care group.

  • Treatment rate was 85.23% in the standardized group versus 58.29% in the routine group.
  • Difference was statistically significant (p < 0.05).
  • The standardized management strategy was supported by the EHR-integrated 'Serum Potassium Management Center System'.

The hyperkalemia standardized group had a significantly higher rate of potassium level review compared to the routine care group.

  • Review rate was 89.41% in the standardized group versus 60.86% in the routine group.
  • Difference was statistically significant (p < 0.05).
  • All three process indicators — diagnosis, treatment, and review — were significantly improved in the standardized group.

The hyperkalemia standardized group was associated with lower hospitalization costs in the CKD-HF and CKD-diabetes mellitus-HF comorbid subgroups.

  • Lower hospitalization costs were observed in both the chronic kidney disease-heart failure (CKD-HF) subgroup and the CKD-diabetes mellitus-heart failure comorbid subgroup (p < 0.05).
  • A non-significant trend toward reduced hospitalization costs was also observed in the CKD subgroup.
  • Results reflect real-world outcomes in a retrospective cohort design.

The hyperkalemia standardized group was associated with shorter hospital stays in the CKD-HF comorbid subgroup.

  • Shorter hospital stays in the CKD-HF subgroup reached statistical significance (p < 0.05).
  • A non-significant trend toward shorter hospital stays was also observed in the CKD subgroup.
  • No statistically significant reduction in hospital stay length was reported for the CKD-DM-HF subgroup specifically.

The study design compared an EHR-integrated standardized management system against routine care across 10,934 hyperkalemia episodes.

  • This was a retrospective real-world study registered with the Chinese Clinical Trial Registry (ChiCTR2600116550) on January 12, 2026.
  • Two cohorts were compared: a hyperkalemia routine group and a hyperkalemia standardized group managed with the 'Serum Potassium Management Center System'.
  • Outcome metrics included both process indicators (diagnosis, treatment, review rates) and disease burden outcomes (hospitalization costs, hospital stay length).
  • Subgroup analyses were conducted based on comorbidity profiles including CKD, CKD-HF, and CKD-DM-HF.

What This Means

This research suggests that integrating a specialized computerized management tool — the 'Serum Potassium Management Center System' — into hospital electronic health records can meaningfully improve how high blood potassium (hyperkalemia) is detected and treated. The study looked at nearly 11,000 episodes of hyperkalemia at a real hospital and found that patients managed with this system were more likely to have their condition properly diagnosed, treated, and followed up on compared to patients who received standard care. Specifically, treatment rates jumped from about 58% to 85%, and follow-up review rates rose from about 61% to 89%. Beyond just improving care processes, the system also appeared to reduce the financial and time burden of hospitalization for certain high-risk patient groups. Patients with both chronic kidney disease and heart failure — a combination that makes hyperkalemia especially dangerous and difficult to manage — had lower hospital bills and shorter stays when their care was guided by the system. A similar trend was seen in patients who also had diabetes, though the results in that group did not reach statistical significance for all outcomes. This research suggests that embedding structured, algorithmic decision-support tools directly into hospital workflows can close gaps in the management of complex conditions like hyperkalemia, particularly for patients with multiple chronic illnesses who are most at risk. The findings highlight the potential of health information technology to standardize care and reduce unnecessary healthcare resource use in real-world clinical settings.

Have a question about this study?

Citation

Lyu G, Zhang F, Fan X, Li R, Zhou X. (2026). Clinical impact of an EHR-integrated hyperkalemia management system: a real-world study of 10,934 episodes.. Renal failure. https://doi.org/10.1080/0886022X.2026.2680349